These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 4899084)

  • 1. [Insulin liberation from the pancreas by sulfonylurea].
    Pfaff W; Schöne HH
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1445-8. PubMed ID: 4899084
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypoglycemic sulfonamides].
    Loubatières AL
    Actual Pharmacol (Paris); 1968; 21():173-90. PubMed ID: 4888764
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].
    Loubatières A; Mariani MM; Ribes G; de Malbosc H; Alric R; Chapal J
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1354-63. PubMed ID: 4899083
    [No Abstract]   [Full Text] [Related]  

  • 4. [Light-optic morphological studies on the B-cells of the islets of langerhans after administration of HB 419].
    Bänder A; Pfaff W; Schesmer G
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1448-51. PubMed ID: 4899085
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of the beta-cytotrophic effect of a new sulfonylurea derivative, glibornuride, and tolbutamide].
    Bottermann P; Souvatzoglou A; Schwarz K; Rettig M
    Klin Wochenschr; 1971 Jul; 49(13):769-70. PubMed ID: 4935073
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative studies between HB 419 (glibenclamide) and tolbutamide on their effect on insulin liberation in isolated islands of rat pancreas in vitro].
    Weinges KF; Biro G; Kettl H; Mitzuno M
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1467-9. PubMed ID: 4899089
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A; Ribes G; Mariani MM; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract]   [Full Text] [Related]  

  • 8. [Quantitative pharmacodynamics with an endocrine cell: sulfonylureas and insulin secretion].
    Alric R; Portal A
    Therapie; 1969; 24(5):871-80. PubMed ID: 5364207
    [No Abstract]   [Full Text] [Related]  

  • 9. Suppression of pancreatic glucagon release by the hypoglycaemic sulphonylureas.
    Samols E; Tyler JM; Mialhe P
    Lancet; 1969 Jan; 1(7587):174-6. PubMed ID: 4178416
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of blood sugar decreasing sulfonylureas on the in vitro metabolism of glucose and amino acids in the beta-cells of the pancreas in mice].
    Hellerström C; Westman S; Stork H; Schmidt FH
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1464-7. PubMed ID: 4899088
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of tolbutamide on insulin and glucagon secretion of the isolated perfused rat pancreas.
    Laube H; Fussgänger R; Goberna R; Schröder K; Straub K; Sussman K; Pfeiffer EF
    Horm Metab Res; 1971 Jul; 3(4):238-42. PubMed ID: 4256979
    [No Abstract]   [Full Text] [Related]  

  • 12. [Normal histology of the beta-cells during insulin secretion].
    Bänder A
    Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():417-35. PubMed ID: 4907224
    [No Abstract]   [Full Text] [Related]  

  • 13. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
    Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K
    Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
    [No Abstract]   [Full Text] [Related]  

  • 14. [Regulation of insulin release in perifused pancreatic tissue].
    Burr IM; Renold AE; Stauffacher W; Grodsky GM; Balant L
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():580-96. PubMed ID: 4906025
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucagon secretion from the isolated perfused rat pancreas: influenced by the glucose-, tolbutamide- and pancreozymin-mediated release of pancreatic insulin.
    Fussgänger RD; Goberna R; Laube H; Schröder KE; Straub K; Pfeiffer EF
    Isr J Med Sci; 1972 Jun; 8(6):768-9. PubMed ID: 4559419
    [No Abstract]   [Full Text] [Related]  

  • 16. Zinc and insulin content in pancreatic islets of rats after administration of hypoglycemic sulfonamides.
    Lazaris YA; Kuts LG; Bavel'skii ZE
    Bull Exp Biol Med; 1974 Dec; 77(6):647-9. PubMed ID: 4216382
    [No Abstract]   [Full Text] [Related]  

  • 17. Uptake of glibornuride by microdissected pancreatic islets.
    Täljedal IB
    Horm Res; 1974; 5(4):211-6. PubMed ID: 4210148
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypoglycemic drugs.
    Stehling L
    Clin Anesth; 1974; 10(1):233-47. PubMed ID: 4598996
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current pathophysiological and clinical aspects of the mode of action of blood glucose lowering sulfonamides].
    Pfeiffer EF
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():477-502. PubMed ID: 4906024
    [No Abstract]   [Full Text] [Related]  

  • 20. [The functional behaviour of zinc and insulin contained in the pancreatic beta-cells of rats].
    Engelbart K; Kief H
    Virchows Arch B Cell Pathol; 1970; 4(4):294-302. PubMed ID: 4190078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.